The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl 3-(2-cyanoethyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate ID: ALA4103790
PubChem CID: 137656625
Max Phase: Preclinical
Molecular Formula: C17H18N4O5
Molecular Weight: 358.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C1=C(C)NC(=O)N(CCC#N)C1c1cccc([N+](=O)[O-])c1
Standard InChI: InChI=1S/C17H18N4O5/c1-3-26-16(22)14-11(2)19-17(23)20(9-5-8-18)15(14)12-6-4-7-13(10-12)21(24)25/h4,6-7,10,15H,3,5,9H2,1-2H3,(H,19,23)
Standard InChI Key: UJZWRUVZABWVRL-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
6.3186 -13.3090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3072 -12.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5946 -12.0926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8933 -12.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9006 -13.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6132 -13.7268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1807 -12.1070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4753 -12.5248 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1694 -11.2899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0312 -13.7083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5833 -11.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2845 -10.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2773 -10.0406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5647 -9.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8593 -10.0550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8707 -10.8721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9786 -9.6228 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9673 -8.8057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6912 -10.0221 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1993 -13.7412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0085 -12.0741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7211 -12.4733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7325 -13.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7438 -14.1075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4568 -10.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4454 -10.0735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 2 0
7 9 1 0
4 7 1 0
1 10 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 2 0
17 19 1 0
13 17 1 0
3 11 1 0
5 20 1 0
21 22 1 0
23 24 3 0
22 23 1 0
2 21 1 0
25 26 1 0
9 25 1 0
M CHG 2 17 1 19 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.35Molecular Weight (Monoisotopic): 358.1277AlogP: 2.41#Rotatable Bonds: 6Polar Surface Area: 125.57Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.68CX Basic pKa: ┄CX LogP: 1.18CX LogD: 1.18Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: -1.47
References 1. Teleb M, Zhang FX, Farghaly AM, Aboul Wafa OM, Fronczek FR, Zamponi GW, Fahmy H.. (2017) Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers., 134 [PMID:28399450 ] [10.1016/j.ejmech.2017.03.080 ]